سعر بونفوري 20مجم 28 قرص 2026

Ponvory 20 mg 28 f.c.tabs. (maintenance pack)

معلومات الدواء

دواعي الاستعمالUses

Relapsing forms of multiple sclerosis (clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease) in adults.الفئة: AdultsDailyMed (U.S. National Library of Medicine)

Relapsing forms of multiple sclerosis (clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease) in adults.Population: AdultsDailyMed (U.S. National Library of Medicine)

الآثار الجانبيةSide effects

Most common adverse reactions (at least 10%): upper respiratory tract infection, hepatic transaminase elevation and hypertension.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

Most common adverse reactions (at least 10%): upper respiratory tract infection, hepatic transaminase elevation and hypertension.International label, same formulation · DailyMed (U.S. National Library of Medicine)

موانع الاستعمالContraindications

In the last 6 months: myocardial infarction, unstable angina, stroke, TIA, decompensated heart failure requiring hospitalization, or Class III/IV heart failure.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
Mobitz type II second-degree or third-degree AV block, sick sinus syndrome or sino-atrial block, unless a functioning pacemaker is present.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

In the last 6 months: myocardial infarction, unstable angina, stroke, TIA, decompensated heart failure requiring hospitalization, or Class III/IV heart failure.International label, same formulation · DailyMed (U.S. National Library of Medicine)
Mobitz type II second-degree or third-degree AV block, sick sinus syndrome or sino-atrial block, unless a functioning pacemaker is present.International label, same formulation · DailyMed (U.S. National Library of Medicine)

تحذيرات واحتياطاتWarnings & precautions

Infections: may increase infection risk; obtain a CBC before starting, do not start during active infection, and monitor for infection during treatment and for 1-2 weeks after stopping.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
Bradyarrhythmia and AV conduction delays at initiation: titration is required; first-dose 4-hour monitoring for patients with sinus bradycardia, first- or second-degree (Mobitz I) AV block, or prior MI/heart failure.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
Other warnings: decline in pulmonary function, liver injury, increased blood pressure, cutaneous malignancies (skin examination recommended), and fetal risk (effective contraception during treatment and for about 1 week after stopping).نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

Infections: may increase infection risk; obtain a CBC before starting, do not start during active infection, and monitor for infection during treatment and for 1-2 weeks after stopping.International label, same formulation · DailyMed (U.S. National Library of Medicine)
Bradyarrhythmia and AV conduction delays at initiation: titration is required; first-dose 4-hour monitoring for patients with sinus bradycardia, first- or second-degree (Mobitz I) AV block, or prior MI/heart failure.International label, same formulation · DailyMed (U.S. National Library of Medicine)
Other warnings: decline in pulmonary function, liver injury, increased blood pressure, cutaneous malignancies (skin examination recommended), and fetal risk (effective contraception during treatment and for about 1 week after stopping).International label, same formulation · DailyMed (U.S. National Library of Medicine)

الحمل والرضاعةPregnancy & breastfeeding

No adequate studies in pregnant women; in rats and rabbits ponesimod caused embryolethality and fetal malformations at clinically relevant exposures. Women of childbearing potential should use effective contraception.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
No data on presence in human milk; consider benefits of breastfeeding against the mother's need for ponesimod and potential infant effects.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

No adequate studies in pregnant women; in rats and rabbits ponesimod caused embryolethality and fetal malformations at clinically relevant exposures. Women of childbearing potential should use effective contraception.International label, same formulation · DailyMed (U.S. National Library of Medicine)
No data on presence in human milk; consider benefits of breastfeeding against the mother's need for ponesimod and potential infant effects.International label, same formulation · DailyMed (U.S. National Library of Medicine)

مادة فعالة مختلفة من نفس المجموعة العلاجية. لا تستبدل دواءك ببديل إلا بأمر الطبيب.

بدائل بونفوري 20مجم 28 قرص من نفس المجموعة العلاجية بمادة فعالة مختلفة، مرتبة من الأرخص
الدواء	السعر
مايزينت 0.25 مجم 12 قرصMayzent 0.25 mg 12 film-coated tabletsNovartis Pharma Scientific Office · قرص مغلف · 0.25 mg	السعر2,197ج.م183.08ج.م للوحدة
سفينجومود 0.5 مجم 28 كبسولةSphingomod 0.5 mg capsulesHikma Specialized Pharmaceuticals · كبسولة · 0.5 mg	السعر6,634ج.م236.93ج.م للوحدة
فينليمود 5.مجم 28 كبسولةFinlimod 0.5 mg 28 capsBiogeneric Pharma · كبسولة · 0.5 mg	السعر7,137ج.م254.89ج.م للوحدة
جيلينيا 0.5 مجم 28 كبسولةGilenya 0.5mg 28 capsNovartis · كبسولة صلبة · 0.5 mg	السعر16,850ج.م601.79ج.م للوحدة
مايزنت 0.25مجم 120 قرصMayzent 0.25 mg 120 film-coated tabletsNovartis Pharma Scientific Office · قرص مغلف · 0.25 mg	السعر19,465ج.م162.21ج.م للوحدة
ماي زنت 2مجم 28 قرصMayzent 2 mg 28 film-coated tabletsNovartis Pharma Scientific Office · قرص مغلف · 2 mg	السعر20,630ج.م736.79ج.م للوحدة

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.